Neuromuscular Blockade: Difference between revisions

Neuromuscular Blockade (view source)

160 bytes added , 1 year ago

no edit summary

3,688

edits

Revision as of 11:37, 24 October 2023 (view source) WikiSysop (talk \| contribs) No edit summary ← Older edit		Revision as of 15:47, 21 November 2023 (view source) WikiSysop (talk \| contribs) No edit summary Newer edit →
Line 84:		Line 84:

	Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age. Paediatr Anaesth. 2023 Oct 4. doi: 10.1111/pan.14773. Epub ahead of print. PMID: 37792601		Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age. Paediatr Anaesth. 2023 Oct 4. doi: 10.1111/pan.14773. Epub ahead of print. PMID: 37792601

			[https://www.bjanaesthesia.org/article/S0007-0912(23)00548-2/fulltext Recurarisation after sugammadex in children: review of case reports and recommendations]